Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Coding Corner Question

From the College  |  Issue: December 2010  |  December 1, 2010

A 54-year-old female with rheumatoid arthritis (RA) and osteoporosis (OP) returns to the rheumatology practice for a follow-up visit. She reports that the pain in her hands and feet is slightly worse than last visit. She has morning stiffness for one hour with increased fatigue and swelling in her fingers. She continues to have dry eyes and mouth. She denies fever, chills, cough, and shortness of breath, and she has no rashes.

She denies any night vision cueing. She’s had no falls or fractures. Her past medical history was reviewed with no additions and no new surgeries. She has no known allergies. There was no change to family or social history since January of this year. Her current medications include methotrexate, low dose prednisone, Plaquenil, Fosamax, folic acid, calcium, and vitamin D.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The physical examination reveals a well female in no apparent distress. Her vital signs are a blood pressure of 140/ 90, a pulse of 88, a temperature of 98.6° F, a weight of 150 pounds, and a height of 5’6”. A head, eyes, ears, nose, and throat exam is within normal limits, except for dry mucous membranes. Her neck is within normal limits. Her cardiovascular and lung exam are normal. Her abdomen and skin are normal. A complete joint exam shows swelling of the metacarpohalangeal joints bilateral and all metatarsophalangeal joints. There are no deformities. She has a flat affect.

Assessment

  1. RA, worse on chronic medicine
  2. OP, stable on chronic medicine
  3. Elevated blood pressure, new problem

Plan

  1. Start a tumor necrosis factor inhibitor. A skin test and chest X-ray was ordered for a tuberculosis screen. Labs were ordered for disease evaluation and medication monitoring. She is to continue other medicines. The physician held a lengthy discussion with patient concerning risks and benefits.
  2. An OP dual-energy X-ray absorptiometry was due and ordered to re-assess. The patient was asked to continue Fosamax, calcium, and vitamin D.
  3. The patient was asked to check her blood pressure at home and keep a log of its results.
  4. Labs were ordered to check toxicity level of drugs. A complete blood count, comprehensive metabolic panel, erythrocyte sedimentation rate, C-reactive protein, and hepatitis panel were ordered due to disease and medicines.

How should this be coded? Click here for the answer.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Case by Melesia Tillman, CPC, CRHC, CHA, coding specialist for the ACR.

Share: 

Filed under:Billing/CodingConditionsFrom the CollegeOsteoarthritis and Bone DisordersPractice Support Tagged with:BillingCodingOsteoporosisRheumatoid arthritis

Related Articles

    Drug Updates

    November 1, 2009

    Information on News Approvals and Medication Safety

    Improve RA Care with Vitamin D

    November 16, 2015

    Background Autoimmune diseases, such as rheumatoid arthritis (RA) and systemic lupus erythema­tous, occur when the body attacks its own tissue because it cannot differentiate between self and non-self. This is mainly through deregulation of the immune system. Vitamin D has been known to play a critical role in bone mineralization and bone health. Activated vitamin…

    Persistent Symptomatic Hypocalcemia Due to Denosumab: A Case Review

    October 1, 2014

    Patients with osteoporosis and impaired renal function are at risk

    Vitamin D in Rheumatology: Cause and Effect Unclear

    September 15, 2015

    The controversy over vitamin D is hearty enough to confuse even seasoned rheumatologists, says Nathan Wei, MD, The Arthritis Treatment Center, Frederick, Md. “It’s like what you hear with coffee. One week, [a study finds] coffee is … good for you; the next week, there’s a study saying it’s bad for you,” he says. ad…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences